VRI, ANRS and Novasep announce the signature of an agreement for the production of 2 candidate vaccines against HIV, developed by teams at VRI. Process development and production of a prophylactic and a therapeutic vaccine will be performed under current good manufacturing practice (cGMP) conditions by GTP Technology and Novasep respectively, the 2 contract development and manufacturing companies (CDMOs) selected for these important steps in the development of these vaccines.
